These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
82 related articles for article (PubMed ID: 6634849)
1. Central nervous system noradrenaline metabolism and alcohol consumption in man. Borg S; Kvande H; Mossberg D; Valverius P; Sedvall G Pharmacol Biochem Behav; 1983; 18 Suppl 1():375-8. PubMed ID: 6634849 [TBL] [Abstract][Full Text] [Related]
2. Central norepinephrine metabolism during alcohol intoxication in addicts and healthy volunteers. Borg S; Kvande H; Sedvall G Science; 1981 Sep; 213(4512):1135-7. PubMed ID: 7268421 [TBL] [Abstract][Full Text] [Related]
3. Clinical conditions and concentrations of MOPEG in the cerebrospinal fluid and urine of male alcoholic patients during withdrawal. Borg S; Czarnecka A; Kvande H; Mossberg D; Sedvall G Alcohol Clin Exp Res; 1983; 7(4):411-5. PubMed ID: 6362467 [TBL] [Abstract][Full Text] [Related]
4. Norepinephrine metabolite in CSF correlates with ethanol consumption and heredity in humans. Valverius P; Högström-Brandt AM; Borg S Alcohol; 1993; 10(6):499-503. PubMed ID: 8123208 [TBL] [Abstract][Full Text] [Related]
5. [Physiological role and clinical significance of 3-methoxy-4-hydroxyethyleneglycol, a noradrenaline metabolite (review of the literature)]. Bol'shakova TD; Shenderovich MIa Vopr Med Khim; 1987; 33(6):3-11. PubMed ID: 3328414 [TBL] [Abstract][Full Text] [Related]
6. Effect of amphetamine and fenfluramine on brain noradrenaline and MOPEG-SO4. Calderini G; Morselli PL; Garattini S Eur J Pharmacol; 1975 Dec; 34(2):345-50. PubMed ID: 1234553 [TBL] [Abstract][Full Text] [Related]
7. A method for the assay of conjugated 3,4-dihydroxyphenylglycol, a major noradrenaline metabolite in the rat brain. Nielsen M; Braestrup C J Neurochem; 1976 Nov; 27(5):1211-7. PubMed ID: 12170609 [TBL] [Abstract][Full Text] [Related]
8. Short and long-term effects of reserpine on the concentration of 1-(4-hydroxy-3-methoxyphenyl)-ethane-1,2-diol (MOPEG-SO4) in the brain of the rat. Bareggi SR; Genovese E; Markey K Br J Pharmacol; 1979 Apr; 65(4):573-8. PubMed ID: 435682 [TBL] [Abstract][Full Text] [Related]
9. 3-Methoxy-4-hydroxy-phenylglycol sulfate (MOPEG-SO4) in ventricular and cisternal cerebrospinal fluid of dogs. Bareggi SR; Stabenau JR; Shaskan EG; Becker RE; Roberts M J Neurosci Res; 1975; 1(5-6):471-4. PubMed ID: 1226000 [TBL] [Abstract][Full Text] [Related]
10. Relationships in healthy volunteers between secretion of monoamine metabolites in urine, and family history of psychiatric morbidity. Wiesel FA; Fyrö B; Nybäck H; Sedvall G; Wode-Helgodt B Biol Psychiatry; 1982 Dec; 17(12):1403-13. PubMed ID: 6186299 [TBL] [Abstract][Full Text] [Related]
11. Intra- and extraneuronal formation of the two major noradrenaline metabolites in the cns of rats. Braestrup C; Nielsen M J Pharm Pharmacol; 1975 Jun; 27(6):413-9. PubMed ID: 237089 [TBL] [Abstract][Full Text] [Related]
12. Regulation in the central norepinephrine neurotransmission induced in vivo by alpha adrenoceptor active drugs. Braestrup C; Nielsen M J Pharmacol Exp Ther; 1976 Sep; 198(3):596-608. PubMed ID: 185355 [TBL] [Abstract][Full Text] [Related]
13. Analgesia and increases in limbic and cortical MOPEG-SO4 produced by periaqueductal gray injections of morphine. Reigle TG; Wilhoit CS; Moore MJ J Pharm Pharmacol; 1982 Aug; 34(8):496-500. PubMed ID: 6126559 [TBL] [Abstract][Full Text] [Related]
14. 3-Methoxy-4-hydroxyphenylglycol sulphate (MOPEG-SO4) as an index of cerebral noradrenaline turnover following depletion of transmitter stores in the rat. Dolphin A; Jenner P; Marsden CD J Pharm Pharmacol; 1978 Sep; 30(9):580-2. PubMed ID: 29100 [No Abstract] [Full Text] [Related]
15. The effect of trauma on the activity of central noradrenergic neurones. Stoner HB; Hunt A Brain Res; 1976 Aug; 112(2):337-46. PubMed ID: 953712 [TBL] [Abstract][Full Text] [Related]
16. [Study of the metabolism of cerebral noradrenaline in depressed patients by the assay of plasma dihydroxyphenylethylene glycol]. Loo H; Scatton B; Poirier MF; Benkelfat C; Dennis T; Vanelle JM; Garreau M; Sechter D Presse Med; 1985 Jun; 14(25):1363-6. PubMed ID: 3161030 [TBL] [Abstract][Full Text] [Related]
17. Plasma 3,4-dihydroxyphenylethyleneglycol and 3-methoxy-4-hydroxyphenylethyleneglycol as indicators of central noradrenergic activity. A comparative study on control subjects and depressed patients. Azorin JM; Karege F; Valli M; Pringuey D; Joanny P; Tissot R Neuropsychobiology; 1988; 20(2):67-73. PubMed ID: 3075724 [TBL] [Abstract][Full Text] [Related]
18. [Circadian rhythms of adrenaline and noradrenaline excretion in man in normal conditions and after alcohol intake]. Latenkov VP Biull Eksp Biol Med; 1985 Mar; 99(3):344-6. PubMed ID: 3986344 [TBL] [Abstract][Full Text] [Related]
19. Effects of clonidine on central and peripheral catecholamine metabolism. Martin PR; Ebert MH; Gordon EK; Linnoila M; Kopin IJ Clin Pharmacol Ther; 1984 Mar; 35(3):322-7. PubMed ID: 6199153 [TBL] [Abstract][Full Text] [Related]
20. Effect of prazosin on norepinephrine concentration and turnover in rat brain and heart. Fuller RW; Snoddy HD; Perry KW Arch Int Pharmacodyn Ther; 1978 Jan; 231(1):30-41. PubMed ID: 637622 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]